Verduyn-van Weegen Felice Isabel
SEC Form 4 insider trading activity
Verduyn-van Weegen Felice Isabel has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Feb 18, 2026.
On the most recent filing, Verduyn-van Weegen Felice Isabel is listed as Director, 10% Owner at Evommune, Inc. Inside the rolling window, Verduyn-van Weegen Felice Isabel reported 1 open-market purchase totaling $25.0M in EVMN and no open-market sales.
Companies traded
Other insiders at EVMN
Insider Buying
$25.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Verduyn-van Weegen Felice Isabel made?
Verduyn-van Weegen Felice Isabel has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Verduyn-van Weegen Felice Isabel trade?
Verduyn-van Weegen Felice Isabel has filed SEC Form 4 disclosures for 1 company, including EVMN.
When was Verduyn-van Weegen Felice Isabel's most recent SEC Form 4 filing?
Verduyn-van Weegen Felice Isabel's most recent SEC Form 4 filing on Tracefour is dated Feb 18, 2026.
What is Verduyn-van Weegen Felice Isabel's total buy and sell value in the current window?
Inside the rolling retention window, Verduyn-van Weegen Felice Isabel bought $25.0M and sold $0 based on SEC Form 4 filings.
What was Verduyn-van Weegen Felice Isabel's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,562,500 EVMN shares on 2025-11-07, worth $25.0M, per SEC Form 4 filings.